Company intelligence / Profile preview

DiaMonTech

Ownership: Private
Development stage: Preclinical

Overview

DiaMonTech has developed a patented non-invasive blood glucose monitoring technology using infrared laser spectroscopy. The company’s D-Pocket and desktop devices are in advanced development but not yet on the market. Clinical validation data have not been published publicly; however, the company has won multiple innovation awards and attracted strategic partners such as Samsung Ventures. Their approach aims to provide accurate, painless blood sugar measurements within seconds without finger pricks or test strips.

Therapeutic areas: Endocrinology
Modalities: Device (non-invasive glucose monitoring device using infrared laser technology)
Industry: Metabolite Diagnostics

Partnerships

Samsung VenturesUnorthodox Ventures

Beyond the preview

Go deeper on DiaMonTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiaMonTech.

Explore the full profile